ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among 35 adults using technosphere insulin in the INHALE ...

A multi-center study led by a UB pediatric endocrinologist has found that a drug currently on the market for other autoimmune conditions can preserve the beta cells of children and young adults ...

(HealthDay News) — In a small, preliminary study, high-dose insulin capsules safely induced what appears to be a protective immune response in children at high risk of developing type 1 diabetes. The ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

The twiist AID system is designed to directly measure the volume and flow of insulin with every micro-dose, and address an individual’s dosing needs. Using the FDA-cleared Tidepool Loop technology, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The first trial of semaglutide in patients with type 1 ...

Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device includes a ...

A breakthrough in Type 1 diabetes treatment shows promise. Scientists in Sweden have successfully transplanted gene-edited ...

A low-fat vegan diet that doesn’t limit calories or carbohydrates could help people with type 1 diabetes reduce insulin use and insulin costs, according to new research by the Physicians Committee for ...